Chris Torrance

Founder/Chief Executive Officer at Phoremost Ltd.

Chris Torrance

Chris Torrance

Founder/Chief Executive Officer at Phoremost Ltd.

Overview
Career Highlights

Phoremost Ltd.
Horizon Discovery Ltd.
Horizon Discovery Group PLC

RelSci Relationships

1457

Number of Boards

7

Contact Data
Trying to get in touch with Chris Torrance? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Chris Torrance likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Axol Bioscience Ltd.

Relationship likelihood: Strong

Director, Laboratory of Molecular Genetics at University of Torino - The Institute for Cancer Research and Treatment at School of Medicine

Relationship likelihood: Strong

Former Chief Financial Officer, Executive Director, Secretary at Horizon Discovery Group PLC

Relationship likelihood: Strong

Chief Executive Officer at ERS Genomics Ltd.

Relationship likelihood: Strong

Co-Founder & CSO at Phoremost Ltd.

Relationship likelihood: Strong

Co-Founder at Amadeus Capital Partners Ltd.

Relationship likelihood: Strong

Associate Professor at Johns Hopkins University

Relationship likelihood: Strong

Head of Research Operations at Horizon Discovery Group PLC

Relationship likelihood: Strong

Member, Scientific Advisory Board at Horizon Discovery Group PLC

Relationship likelihood: Strong

Member, Scientific Advisory Board at Horizon Discovery Group PLC

Relationship likelihood: Strong

Paths to Chris Torrance
Potential Connections via
Relationship Science
You
Chris Torrance
Founder/Chief Executive Officer at Phoremost Ltd.
Education
Ph.D Unknown

East Carolina University in Greenville, North Carolina boasts several nationally recognized undergraduate and graduate programs. East Carolina offers bachelor’s, master’s, and doctoral degrees through its colleges of business, fine arts, health, dentistry, nursing and others. East Carolina University’s Brody School of Medicine is one of its more impressive divisions. Among medical schools emphasizing primary care Brody ranked sixth by U.S. News and World Report. It also ranked ninth for rural medicine. Also intensely involved in research, Brody is renowned for its innovative work in robotic surgery. Brody’s research is also continually expanding as they are also partnered with several growing research and clinical care facilities. Brody’s education department is also one of its more respected. Graduates of ECU’s College of Education have been named Teachers of the Year at the state and national levels. Another of its notable departments is the College of Fine Arts and Communications. Training individuals in the visual and performing arts, this division is one of the more well-known on the East Coast and hosts numerous performances, exhibits and arts programs. Additional offerings at ECU include adult learning options, a language academy and distance learning. Student services meet a range of needs and include a career center, a writing center, study abroad programs, student government, disability support, counseling, student legal services, a student health center, on-campus housing, financial aid for eligible students, and many others.

Sheffield Hallam University is a public university. It offers higher education services. The University provides courses of study in business, engineering and architecture, medicine, computer sciences, education, language, history, law, journalism, math, and other areas. Additionally, it also provides master, and doctorate levels of education as well. Sheffield Hallam University was founded in 1969 and is headquartered in Sheffield, New Zealand.

Career History
Founder/Chief Executive Officer
2014 - Current

PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can't be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom.

Co-Founder
2005 - Prior

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The company also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. Horizon Discovery was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.

Founder
2005 - Prior

Horizon Discovery Group Plc is a gene editing company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research and Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research and Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in 2005 and is headquartered in Cambridge, the United Kingdom.

Boards & Committees
Member, Scientific Advisory Board
Current

Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The company also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. Horizon Discovery was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom.

Investments
Details Hidden

GeneAdviser Ltd. operates an online ordering platform for genetic test services. It enables doctors and their local laboratories to find and order tests for rare diseases, cancer treatment and personalized medicine. The company was founded by Jelena Aleksic and Robert Stojnic and is headquartered in Cambridge, the United Kingdom.

Details Hidden

PhoreMost Ltd. operates as a drug discovery company. It engages in identifying new druggable targets for cancer and other unmet diseases. PhoreMost uses SiteSeeker technology, a live-cell phenotypic assay system that can identify unexpected, or cryptic druggable sites in specific disease driving targets and pathways that can't be readily seen using conventional non-cell based analytical methods. The company was founded by Christopher John Torrance and Ashok Venkitaraman on April 1, 2014 and is headquartered in Cambridge, the United Kingdom.

Details Hidden

Horizon Discovery Group Plc is a gene editing company, which engages in the design and engineering of genetically-modified cells. The firm operates through the following business segments: Products, Services, and Leveraged Research and Development. The Products segment sells cell lines and other products. The Services segment offers cell line manufacturing services. The Leveraged Research and Development segment business unit is operated on a portfolio basis. It serves pharmaceutical, biotechnology, and diagnostic companies. The company was founded by Christopher John Torrance, Adam John Collier, and Alberto Bardelli in 2005 and is headquartered in Cambridge, the United Kingdom.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Chris Torrance. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Chris Torrance's profile does not indicate a business or promotional relationship of any kind between RelSci and Chris Torrance.